UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 57

Sortiert nach

Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats

The Journal of pharmacology and experimental therapeutics, 2008-07, Vol.326 (1), p.218

2008

Link zum Volltext

Verfügbarkeit prüfen

AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties

The Journal of pharmacology and experimental therapeutics, 2005-04, Vol.313 (1), p.474

2005

Link zum Volltext

Verfügbarkeit prüfen

Species-Specific Pharmacology of Trichloro(Sulfanyl)ethyl Benzamides as Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists

Molecular pain, 2007-12, Vol.3 (1), p.39-39

2007

Link zum Volltext

Verfügbarkeit prüfen

Molecular Determinants of Vanilloid Sensitivity in TRPV1

The Journal of biological chemistry, 2004-05, Vol.279 (19), p.20283-20295

2004

Link zum Volltext

Verfügbarkeit prüfen

Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade

The Journal of pharmacology and experimental therapeutics, 2007-10, Vol.323 (1), p.128

2007

Link zum Volltext

Verfügbarkeit prüfen

Proton Activation Does Not Alter Antagonist Interaction with the Capsaicin-Binding Pocket of TRPV1

Molecular pharmacology, 2005-12, Vol.68 (6), p.1524-1533

2005

Link zum Volltext

Verfügbarkeit prüfen

A polyclonal antibody to the prepore loop of transient receptor potential vanilloid type 1 blocks channel activation

The Journal of pharmacology and experimental therapeutics, 2006-10, Vol.319 (1), p.192

2006

Link zum Volltext

Verfügbarkeit prüfen

Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1H-benzimidazoles

Journal of medicinal chemistry, 2006-06, Vol.49 (12), p.3719-3742

2006

Link zum Volltext

Verfügbarkeit prüfen

KTP/532 YAG laser treatment for allergic rhinitis

American journal of rhinology & allergy, 2009-09, Vol.23 (5), p.527-530

2009

Link zum Volltext

Verfügbarkeit prüfen

The Vanilloid Receptor TRPV1 Is Tonically Activated In Vivo and Involved in Body Temperature Regulation

The Journal of neuroscience, 2007-03, Vol.27 (13), p.3366-3374

2007

Link zum Volltext

Verfügbarkeit prüfen

Design and Synthesis of Peripherally Restricted Transient Receptor Potential Vanilloid 1 (TRPV1) Antagonists

Journal of medicinal chemistry, 2008-05, Vol.51 (9), p.2744-2757

2008

Link zum Volltext

Verfügbarkeit prüfen

Novel Vanilloid Receptor-1 Antagonists: 2. Structure−Activity Relationships of 4-Oxopyrimidines Leading to the Selection of a Clinical Candidate

Journal of medicinal chemistry, 2007-07, Vol.50 (15), p.3515-3527

2007

Link zum Volltext

Verfügbarkeit prüfen

GDNF–Induced Activation of the Ret Protein Tyrosine Kinase Is Mediated by GDNFR-α, a Novel Receptor for GDNF

Cell, 1996-06, Vol.85 (7), p.1113-1124

1996

Link zum Volltext

Verfügbarkeit prüfen

Novel Vanilloid Receptor-1 Antagonists: 3. The Identification of a Second-Generation Clinical Candidate with Improved Physicochemical and Pharmacokinetic Properties

Journal of medicinal chemistry, 2007-07, Vol.50 (15), p.3528-3539

2007

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2058: Translational regulation of SPARC by the microRNAs mir29a, b, and c

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.2058-2058

2010

Link zum Volltext

Verfügbarkeit prüfen

Discovery of Potent, Orally Available Vanilloid Receptor-1 Antagonists. Structure−Activity Relationship of N-Aryl Cinnamides

Journal of medicinal chemistry, 2005-01, Vol.48 (1), p.71-90

2005

Link zum Volltext

Verfügbarkeit prüfen

Novel Vanilloid Receptor-1 Antagonists: 1. Conformationally Restricted Analogues of trans-Cinnamides

Journal of medicinal chemistry, 2007-07, Vol.50 (15), p.3497-3514

2007

Link zum Volltext

Verfügbarkeit prüfen

Structure–activity relationship (SAR) investigations of substituted imidazole analogs as TRPV1 antagonists

Bioorganic & medicinal chemistry letters, 2007-11, Vol.17 (21), p.5825-5830

2007

Link zum Volltext

Verfügbarkeit prüfen

Generation of suppressor cells in atopic patients during immunotherapy that modulate IgE synthesis

Journal of allergy and clinical immunology, 1987-04, Vol.79 (4), p.591-598

1987

Link zum Volltext

Verfügbarkeit prüfen

Substituted aryl pyrimidines as potent and soluble TRPV1 antagonists

Bioorganic & medicinal chemistry, 2008-09, Vol.18 (18), p.5118-5122

2008

Link zum Volltext

Verfügbarkeit prüfen

Trisubstituted pyrimidines as transient receptor potential vanilloid 1 (TRPV1) antagonists with improved solubility

Bioorganic & medicinal chemistry, 2007-12, Vol.17 (23), p.6539-6545

2007

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists

Bioorganic & medicinal chemistry letters, 2005-12, Vol.15 (23), p.5211-5217

2005

Link zum Volltext

Verfügbarkeit prüfen

Species-specific pharmacology of Trichloro antagonists

Molecular pain, 2007-12, Vol.3, p.39

2007

Link zum Volltext

Verfügbarkeit prüfen

4-Aminopyrimidine tetrahydronaphthols: A series of novel vanilloid receptor-1 antagonists with improved solubility properties

Bioorganic & medicinal chemistry, 2008-03, Vol.18 (6), p.1830-1834

2008

Link zum Volltext

Verfügbarkeit prüfen

Differences in the prevalence of asthma and current wheeze between Jews and Arabs: results from a national survey of schoolchildren in Israel

Annals of allergy, asthma, & immunology, 2002-10, Vol.89 (4), p.386-392

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(56)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(39)
Humans
(31)
Male
(25)
Biological And Medical Sciences
(23)
Animals
(21)
Medical Sciences
(21)
Rats
(19)
Female
(17)
Pharmacology & Pharmacy
(17)
Cricetinae
(16)
Trpv Cation Channels - Antagonists & Inhibitors
(15)
Cho Cells
(14)
Cricetulus
(13)
Rats, Sprague-Dawley
(13)
Adult
(12)
Chemistry, Medicinal
(11)
Pharmacology. Drug Treatments
(11)
Structure-Activity Relationship
(11)
Adolescent
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3-dihydro-1H-inden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl)-acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats

AMG 9810 [(E)-3-(4-t-butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a novel vanilloid receptor 1 (TRPV1) antagonist with antihyperalgesic properties

Species-Specific Pharmacology of Trichloro(Sulfanyl)ethyl Benzamides as Transient Receptor Potential Ankyrin 1 (TRPA1) Antagonists

Molecular Determinants of Vanilloid Sensitivity in TRPV1

Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade

Proton Activation Does Not Alter Antagonist Interaction with the Capsaicin-Binding Pocket of TRPV1

A polyclonal antibody to the prepore loop of transient receptor potential vanilloid type 1 blocks channel activation

Design of Potent, Orally Available Antagonists of the Transient Receptor Potential Vanilloid 1. Structure−Activity Relationships of 2-Piperazin-1-yl-1H-benzimidazoles

KTP/532 YAG laser treatment for allergic rhinitis

The Vanilloid Receptor TRPV1 Is Tonically Activated In Vivo and Involved in Body Temperature Regulation

Design and Synthesis of Peripherally Restricted Transient Receptor Potential Vanilloid 1 (TRPV1) Antagonists

Novel Vanilloid Receptor-1 Antagonists: 2. Structure−Activity Relationships of 4-Oxopyrimidines Leading to the Selection of a Clinical Candidate

GDNF–Induced Activation of the Ret Protein Tyrosine Kinase Is Mediated by GDNFR-α, a Novel Receptor for GDNF

Novel Vanilloid Receptor-1 Antagonists: 3. The Identification of a Second-Generation Clinical Candidate with Improved Physicochemical and Pharmacokinetic Properties

Abstract 2058: Translational regulation of SPARC by the microRNAs mir29a, b, and c

Discovery of Potent, Orally Available Vanilloid Receptor-1 Antagonists. Structure−Activity Relationship of N-Aryl Cinnamides

Novel Vanilloid Receptor-1 Antagonists: 1. Conformationally Restricted Analogues of trans-Cinnamides

Structure–activity relationship (SAR) investigations of substituted imidazole analogs as TRPV1 antagonists

Generation of suppressor cells in atopic patients during immunotherapy that modulate IgE synthesis

Substituted aryl pyrimidines as potent and soluble TRPV1 antagonists

Trisubstituted pyrimidines as transient receptor potential vanilloid 1 (TRPV1) antagonists with improved solubility

Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists

Species-specific pharmacology of Trichloro antagonists

4-Aminopyrimidine tetrahydronaphthols: A series of novel vanilloid receptor-1 antagonists with improved solubility properties

Differences in the prevalence of asthma and current wheeze between Jews and Arabs: results from a national survey of schoolchildren in Israel

Suchergebnisse filtern